Population and Biostatistics Department, Faculty of Public Health, Universitas Indonesia, Depok, Indonesia.
Menzies Centre for Health Policy, University of Sydney, Sydney, NSW, Australia.
BMC Womens Health. 2022 Dec 2;22(1):489. doi: 10.1186/s12905-022-02094-1.
The use of Method Information Index (MII) indicates whether women contraceptive users receive adequate information about all available contraceptive methods, side effects of the methods, and how to deal with the side effects if experienced-at method initiation.
This study aims to investigate the level of MII scores or the amount of information received by married women users of five modern contraceptives at the time of initiation and changes of its determinants based on the Indonesian Demographic and Health data between 2007 and 2017.
Data of married women who used most common five modern contraceptive methods (the pill, injectables, implants, IUD, and female sterilization), comprised of a total unweighted sample of 35,412 users out of the 32,895; 45,607 and 49,627 women aged 15-49 in the 2007, 2012, and 2017 Indonesian Demographic and Health Survey (IDHS), respectively. The Method Information Index (MII) scores were calculated based on responses to three questions (whether women were told about method-specific side effects, advised what to do if they experienced them, and informed about other available methods). Multivariable logistic regressions with 'time' as an interaction variable were used to assess the influence of time upon the MII scores and its determinants.
The MII scores were 23.84% in 2007, 24.60% in 2012 and 28.65% in 2017. Obviously, over 70% of reproductive-age women contraceptive users were not receiving complete information about modern contraceptives at the time of initiation. After 5 years (2012), only living in the Java Bali region (AOR = 1.34, 95% CI 1.09-1.66) compared to living in other islands, and currently using injectables (AOR = 1.43, 95% CI 1.10-1.87) and currently using implants (AOR = 1.68, 95% CI 1.07-2.63) compared to currently using pills had significantly higher odds of receiving MII information. After 10 years (2017), only one variable (the 'richest' in the wealth quintile category (AOR = 0.70, 95% CI 0.50-0.99) compared to the 'poorest') still showed a significant association with receipt of complete MII information.
Despite the fact that the MII scores increased gradually across the years, interaction with 'survey time' showed that the likelihood of receiving complete MII information was not statistically different in the 5 years (2007-2012) and in the 10 years (2007-2017) period from the reference category in 2007. The authors recommend use of the MII score as an objective measure to evaluate access to MII essential information and to monitor an increase in the informed population in Indonesia.
方法信息指数(MII)的使用表明,避孕药具使用者在开始使用时是否获得了关于所有可用避孕方法、方法副作用以及如果出现副作用如何处理的充分信息。
本研究旨在根据 2007 年至 2017 年印度尼西亚人口与健康调查(IDHS)的数据,调查五种现代避孕药具的已婚女性在开始使用时的 MII 评分或获得的信息量及其决定因素的变化。
数据包括使用最常见的五种现代避孕药具方法(避孕药、注射剂、植入物、宫内节育器和女性绝育)的已婚女性,共包括总未加权样本 35412 名使用者,其中 2007 年、2012 年和 2017 年 IDHS 中 15-49 岁的女性分别为 32895、45607 和 49627 人。MII 评分根据对三个问题的回答计算(妇女是否被告知特定方法的副作用、如果出现副作用应采取什么措施以及是否告知其他可用方法)。使用带有“时间”作为交互变量的多变量逻辑回归来评估时间对 MII 评分及其决定因素的影响。
2007 年 MII 评分为 23.84%,2012 年为 24.60%,2017 年为 28.65%。显然,超过 70%的育龄期女性避孕药具使用者在开始使用时没有获得关于现代避孕药具的完整信息。5 年后(2012 年),与居住在其他岛屿的人相比,仅居住在爪哇巴厘岛地区(优势比[OR] = 1.34,95%置信区间[CI]为 1.09-1.66),以及目前使用注射剂(OR = 1.43,95%CI 为 1.10-1.87)和目前使用植入物(OR = 1.68,95%CI 为 1.07-2.63)与目前使用避孕药具的人相比,获得 MII 信息的可能性显著更高。10 年后(2017 年),只有一个变量(财富五分位数类别中的“最富有”(OR = 0.70,95%CI 为 0.50-0.99)与“最贫穷”相比)仍然与获得完整的 MII 信息存在显著关联。
尽管 MII 评分逐年逐渐增加,但与“调查时间”的交互作用表明,与 2007 年的参考类别相比,在 5 年(2007-2012 年)和 10 年(2007-2017 年)期间获得完整 MII 信息的可能性在统计学上没有差异。作者建议使用 MII 评分作为客观衡量标准,评估获得 MII 基本信息的情况,并监测印度尼西亚知情人口的增加。